Why so many people are having strokes in their 20s, 30s and 40s: ‘We've never had patients so young'
Strokes are on the rise among younger people, with a recent CDC report revealing a 14.6% increase among people aged 18–44 from 2020 to 2022.
While the alarming trend has been stumping medical professionals, one expert has shared some intriguing theories with The Post.
'We've never had patients so young,' said Dr. Mohammad Anadani, Chief of Neuroendovascular Services for the Endeavor Health Neurosciences Institute.
Advertisement
4 Dr. Mohammad Anadani, Chief of Neuroendovascular Services for the Endeavor Health Neurosciences Institute.
Jon Hillenbrand
'We don't think about stroke in 20-year-old patients. We feel more pressure when caring for these patients because they are so young.'
Anadani recently treated not one but two extremely young adults who had a stroke — Ann Fulk, 24, and Aubrey Hasley, 23.
Their strokes came as a huge surprise to, well, everyone — especially since they were both, by all common standards, healthy.
Advertisement
Anadani believes both of their strokes were embolic — which means they originated elsewhere in the body and traveled to the brain instead of forming directly in the brain's blood vessels.
'Both were taking oral contraceptives, which are known to increase the risk of stroke,' he said, noting that Aubrey had a patent foramen ovale (PFO), or a hole in her heart, which likely contributed to her stroke by allowing a clot to bypass the lungs and travel to the brain.
'As for the overall increase in strokes among younger adults, the exact reasons are not fully understood,' he said.
Advertisement
4 Ann Fulk, who had a stroke when she was 23.
Courtesy of Ann Fulk
'However, it's likely related to a rise in traditional cerebrovascular risk factors such as hypertension, diabetes, high cholesterol and obesity.
'Lifestyle factors like increased stress, long working hours and physical inactivity have also been suggested as contributing factors.'
Advertisement
But there are other factors that could be at play. Fulk noted that she was working a lot at the time of her stroke and, as a result, consuming a lot of caffeine.
The product she was drinking contains 200 mg of caffeine per can. Experts recommend no more than 400 mg of caffeine per day for healthy adults.
'While there is no clear evidence directly linking energy drinks to stroke, several studies have reported an increased risk of hypertension and cardiac arrhythmias, such as atrial fibrillation, associated with their use,' Anadani said.
4 Aubrey Hasley, who had a stroke when she was 22.
Courtesy of Aubrey Hasley
'These conditions are known risk factors for stroke, so it is plausible that energy drinks may contribute to an elevated risk, especially in vulnerable individuals,' he noted.
Indeed, Scarsdale cardiologist and TikTok star Dr. Evan Levine has previously told The Post that he considers energy drinks to be one of the four worst drinks for heart health.
Levine also points the finger to the popularity of Adderall and the ease with which it can be obtained — especially with the rise of telehealth companies.
Advertisement
'In April 2024, they find that when you follow them up for eight years, young healthy people aged 20 to 40, they have a 57% higher risk than young healthy people not on these meds,' Levine previously told The Post.
4 'As for the overall increase in strokes among younger adults, the exact reasons are not fully understood,' he said.
stockdevil – stock.adobe.com
Anadani thinks this theory is a solid maybe.
Advertisement
'Regarding Adderall, the evidence is mixed. While most studies did not show a strong association between Adderall use and stroke, some studies did,' he said,
'While energy drinks and Adderall could play a role in the rise of strokes among young adults, they likely contribute to a lesser degree than more well-established risk factors such as obesity, physical inactivity and chronic stress.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
an hour ago
- Miami Herald
CDC warns of deadly disease outbreak in key cruise ports
Before you travel, it's always a good idea to review country-specific health information provided by the Centers for Disease Control and Prevention (CDC), as well as travel safety information provided by the U.S. State Department. These notices and travel advisories provide important information to help U.S. citizens guard their health and safety while traveling abroad - whether on a cruise or another type of trip. Related: US changes travel threat level for controversial Caribbean port Although travelers often focus more attention on destination-specific safety and security threats outlined in travel advisories, it's important to consider travel health notices, too. The CDC recently updated some of these notices, including a vital warning for travelers concerning outbreaks of dengue, a common mosquito-borne disease that can have life-threatening health consequences in some cases. More than 13 million cases of dengue were reported across the Americas and in the Caribbean in 2024, and dengue outbreaks in these areas continue in 2025. Sign up for the Come Cruise With Me newsletter to save money on your next (or your first) cruise. The CDC recently updated its travel health notice about global dengue, warning travelers that a number of countries around the world continue to report increased numbers of cases of the serious disease. In its notice, the CDC also explains that health officials are seeing a concerning rise in the number of dengue cases among U.S. travelers returning from certain countries. Dengue outbreaks are reported regularly in many popular tourist destinations, including cruise ports, in the Caribbean, Central America, South America, Southeast Asia, and the Pacific Islands. Related: Royal Caribbean shares new health warning for cruisepassengers Specific countries currently experiencing dengue outbreaks include: BrazilColombiaComorosCubaEcuador, including the Galápagos IslandsFijiFrench Polynesia, including the island groups of Society Islands (Tahiti, Moorea, and Bora-Bora)Marquesas Islands (Hiva Oa and Ua Huka)Austral Islands (Tubuai and Rurutu)GuadeloupeGuatemalaIranMexicoPakistanPanamaPhilippinesSaint LuciaSamoaSudan, and Tonga. Public health officials in Puerto Rico and the U.S. Virgin Islands have also declared dengue outbreaks. If you're taking a cruise to Puerto Rico, the Virgin Islands, Mexico, Panama, or Saint Lucia, you should be especially careful and take steps to protect yourself from dengue. Be the first to see the best deals on cruises, special sailings, and more. Sign up for the Come Cruise With Me newsletter. Dengue is caused by a virus that's spread by mosquito bites, so the CDC advises travelers visiting risk areas to be diligent about preventing them. The CDC's recommendations for mosquito bite prevention include: Use an Environmental Protection Agency (EPA)-registered insect repellentWear long-sleeved shirts and long pants when outdoorsSleep in an air-conditioned room or room with window screens If you do get mosquito bites during a cruise or other trip to a destination with a dengue risk, there are a few things to know and key symptoms to look out for following your trip. Dengue can take up to two weeks to begin, and illness generally lasts less than a week. Symptoms include fever, headache, nausea, vomiting, rash, muscle and joint pain, and minor bleeding. If you develop a fever or experience other symptoms of dengue, you should see a health care provider and inform them of your travel. Related: CDC says throw this food out after salmonella sickens cruisers In some cases, dengue can become severe within a few hours, quickly turning into a medical emergency that typically requires hospitalization. Severe dengue can lead to hemorrhage (uncontrolled bleeding), shock (seriously low blood pressure), organ failure, and even death. Even if you don't get sick, if you've recently visited a dengue risk area, you should also continue protect yourself from mosquito bites upon your return home to reduce the chance of spreading dengue. The CDC advises that travelers returning from a destination with a dengue risk should take steps to prevent mosquito bites for three weeks in order to avoid spreading dengue to mosquitoes that could spread the virus to other people. (The Arena Group will earn a commission if you book a cruise.) Make a free appointment with Come Cruise With Me's Travel Agent Partner, Postcard Travel, or email Amy Post at amypost@ or call or text her at 386-383-2472. Copyright 2025 The Arena Group, Inc. All Rights Reserved
Time Business News
an hour ago
- Time Business News
When to Choose Strattera Over Adderall
Attention-Deficit/Hyperactivity Disorder (ADHD) affects millions of people worldwide, leading to difficulties with focus, impulsivity, and hyperactivity. While stimulant medications like Adderall are often the first line of treatment, non-stimulant options such as Strattera (atomoxetine) can be a more appropriate choice in certain situations. Understanding when to choose strattera vs adderall involves evaluating factors such as the patient's medical history, potential side effects, risk of substance abuse, and overall treatment goals. When managing depression and anxiety, selecting the appropriate medication is crucial for effective treatment. Both medications in question are popular SSRIs that help balance serotonin levels in the brain, improving mood and emotional stability. In the middle of this discussion, Lexapro vs zoloft often arises as a common comparison due to their similar uses but distinct side effect profiles and dosing schedules. While some patients respond better to one, others may experience fewer adverse effects or more rapid relief with the alternative. Consulting a healthcare provider is essential to tailor the choice to individual needs and medical history. Strattera and Adderall are both approved by the FDA for treating ADHD but function in very different ways. Adderall is a stimulant composed of amphetamine salts that work by increasing the levels of dopamine and norepinephrine in the brain. This results in improved attention, reduced impulsivity, and greater overall concentration. On the other hand, Strattera is a selective norepinephrine reuptake inhibitor (NRI), which means it primarily boosts norepinephrine without significantly impacting dopamine levels. Unlike Adderall, Strattera is not a controlled substance and carries a much lower risk of abuse. One of the primary reasons to choose Strattera over Adderall is when there's a concern about substance misuse or a history of addiction. Adderall is a Schedule II controlled substance due to its high potential for abuse and dependency. For individuals with a history of substance use disorder, Adderall may pose a serious risk. Strattera, being non-stimulant and non-addictive, offers a safer alternative. It allows for effective ADHD management without the risk of reinforcing addictive behaviors, making it particularly useful in populations vulnerable to stimulant misuse. Many individuals with ADHD also suffer from comorbid mental health conditions like anxiety or depression. In such cases, Strattera may be a better option than Adderall. Stimulants like Adderall can exacerbate anxiety symptoms in some patients, leading to increased restlessness, jitteriness, or panic attacks. Strattera, on the other hand, has shown some efficacy in improving symptoms of anxiety and may also provide mild antidepressant effects due to its norepinephrine-enhancing properties. Choosing Strattera can help manage both ADHD and accompanying mood or anxiety disorders without worsening either condition. Adderall, especially the immediate-release version, has a relatively short duration of action, requiring multiple doses throughout the day. Even the extended-release versions may wear off by late afternoon or evening. In contrast, Strattera is taken once daily and offers 24-hour symptom coverage. This can be particularly advantageous for individuals who need consistent control over their ADHD symptoms throughout the day and into the evening. Students, working professionals, or parents managing multiple responsibilities might find this steady effect preferable to the peaks and troughs associated with stimulant medications. While stimulants are effective for many people, they also come with a host of potential side effects, including insomnia, appetite suppression, irritability, increased heart rate, and elevated blood pressure. For some individuals, these side effects can be intolerable or even dangerous, particularly if they have underlying cardiovascular issues. Strattera generally has a milder side effect profile and is not associated with the same degree of appetite suppression or cardiovascular stimulation. Although it has its own set of side effects, such as nausea or fatigue, these are often more manageable and tend to lessen over time. In some clinical scenarios, a non-stimulant medication like Strattera is the preferred first-line treatment. For example, in younger children (especially those under six years of age), stimulants may not be recommended due to potential side effects and lack of data on long-term safety. Pediatricians may opt for Strattera as a gentler initial approach. Additionally, parents who are concerned about the stigma or potential long-term effects of stimulant use may feel more comfortable starting their child on a non-stimulant option. Stimulants such as Adderall can interfere with sleep, especially if taken later in the day. Sleep disturbances are a common complaint among stimulant users and can contribute to irritability, mood swings, and worsening of ADHD symptoms. Strattera is less likely to cause sleep disruption and may even help improve sleep quality for some patients. For individuals who already struggle with insomnia or erratic sleep patterns, Strattera may be the better treatment choice. One of the key differences between Adderall and Strattera is how quickly they take effect. Adderall typically produces noticeable results within hours, making it ideal for patients seeking immediate symptom relief. Strattera, however, requires several days to weeks to build up in the system and reach full therapeutic effect. For patients and clinicians willing to adopt a slower, more gradual treatment approach, this delayed onset can be worthwhile, especially given Strattera's longer-term stability and lower side effect profile. Because Adderall is a controlled substance, it comes with regulatory burdens such as limited refills, stricter prescribing rules, and potential stigma. Some patients or caregivers may prefer a treatment that does not involve these complications. Strattera, being non-controlled, can be prescribed more freely and refilled more easily. This can improve medication adherence and reduce the hassle associated with frequent doctor visits or pharmacy restrictions. In some cases, clinicians may not be completely certain whether a patient's symptoms are primarily due to ADHD or another condition such as anxiety, depression, or trauma-related disorders. Since stimulants can exacerbate certain psychiatric symptoms or produce euphoria, starting with a non-stimulant like Strattera can be a safer way to assess a patient's response without clouding the diagnostic picture. If symptoms improve with Strattera, it may confirm that norepinephrine imbalance plays a role in the condition, guiding future treatment decisions. Choosing between Strattera and Adderall requires a personalized approach that considers the individual's medical history, lifestyle, comorbid conditions, and treatment preferences. While Adderall remains highly effective for many, Strattera presents a viable and often safer alternative for those with substance abuse risks, anxiety, sleep disturbances, or cardiovascular concerns. It is also a strong option for patients seeking all-day symptom coverage or those who prefer to avoid controlled substances. Consulting with a knowledgeable healthcare provider is crucial in determining which medication best aligns with the patient's needs and long-term goals. TIME BUSINESS NEWS
Yahoo
an hour ago
- Yahoo
The 3 Most Overlooked and Subtle Signs of Heart Trouble, According to a Cardiovascular Surgeon
The 3 Most Overlooked and Subtle Signs of Heart Trouble, According to a Cardiovascular Surgeon originally appeared on Men's Fitness. Heart disease remains the leading cause of death in the U.S., but recognizing early warning signs could make all the difference. Jeremy London, M.D. is a board certified cardiothoracic surgeon with over 25 years of clinical experience. In a new Instagram post, he shared three of the most common potential heart symptoms you shouldn't ignore. As he says near the end of the video, our bodies have built-in warning systems, and addressing any red flags could save your first and biggest red flag is chest pain. "Or more commonly, chest pressure. It's brought on with activity and relieved with rest, and this is an indication that a portion of the heart muscle may be blood starved," he says. This is referred to as stable angina. The second is more subtle: shortness of breath, particularly associated with activity. "But it's progressive shortness of breath. In other words, it's getting worse over time," he clarifies. The final one is the most subtle of the symptoms, and it's a decrease in exercise tolerance. "Now, we all get tired, but what I'm talking about is fatigue out of proportion to the activity. In other words, like taking out the garbage, taking a shower, crossing the parking lot of the supermarket and having to stop," London says. According to the CDC, heart disease is the leading cause of death for men and women alike. Every 33 seconds, one person dies from cardiovascular disease. In 2022 alone, 702,880 people died from heart disease—the equivalent of one in every five deaths. The key to avoiding becoming part of that statistic is responding to any red flags before you get into 3 Most Overlooked and Subtle Signs of Heart Trouble, According to a Cardiovascular Surgeon first appeared on Men's Fitness on Jun 4, 2025 This story was originally reported by Men's Fitness on Jun 4, 2025, where it first appeared.
